Acute respiratory distress syndrome: Shifting the emphasis from treatment to prevention

Current Opinion in Critical Care

Volumn 22, Issue 1, 2016, Pages 21-37

  Gong, Michelle Ng ^a,b   Thompson, B Taylor ^c  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; Clinical trials; Prevention

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; BEVACIZUMAB; BUDESONIDE; CITRULLINE; DEXMEDETOMIDINE; FORMOTEROL; KETOCONAZOLE; METHYLPREDNISOLONE; PROPOFOL; RECOMBINANT ENZYME; SALMETEROL; SIMVASTATIN;

ADULT RESPIRATORY DISTRESS SYNDROME; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; HUMAN; LUNG VENTILATION; OUTCOME ASSESSMENT; PREVENTION STUDY; PRIMARY PREVENTION; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION; CLINICAL TRIAL (TOPIC); FEMALE; FORECASTING; MALE; MORTALITY; PREVENTIVE MEDICINE; PROCEDURES; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES;

CLINICAL TRIALS AS TOPIC; FEMALE; FORECASTING; HUMANS; MALE; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84952716208     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000275     Document Type: Review

References (60)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New Engl J Med 2000; 342: 1301-1308.
3. Taccone P, Pesenti A, Latini R, et al. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA 2009; 302: 1977-1984.
4. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluidmanagement strategies in acute lung injury. New Engl J Med 2006; 354: 2564-2575.
5. Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2000; 303: 865-873.
6. Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533.
7. Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2000; 181: 1121-1127.
8. Soto GJ, Frank AJ, Christiani DC, Gong MN. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med 2012; 40: 2601-2608.
9. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754-1758.
10. Afessa B, Keegan MT, Mohammad Z, et al. Identifying potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 2004; 126: 1905-1909.
11. Rubenfeld G. Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome. Ann Am Thorac Soc 2015; 12 (Supplement 1): s58-s63.
12. Vincent JL. We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 2010; 38 (10 Suppl): S534-538.
13. Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd. Early steroid therapy for respiratory failure. Arch Surg 1985; 120: 536-540.
14. Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138: 62-68.
15. Slotman GJ, Burchard KW, D'Arezzo A, Gann DS. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988; 28: 648-654.
16. Yu M, Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993; 21: 1635-1642.
17. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236: 814-822.
18. Schuster DP, Metzler M, Opal S, et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med 2003; 31: 1612-1619.
19. Manzano F, Fernandez-Mondejar E, Colmenero M, et al. Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients. Crit Care Med 2008; 36: 2225-2231.
20. Esteban A, Frutos-Vivar F, Ferguson ND, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35: 1284-1289.
21. Bulger EM, Jurkovich GJ, Nathens AB, et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg 2008; 143: 139-148; discussion 149.
22. Shyamsundar M, McAuley DF, Shields MO, et al. Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial. Ann Surg 2014; 259: 26-31.
23. Determann RM, Royakkers A, Wolthuis EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Critical care 2010; 14: R1.
24. Onorati F, Santini F, Mariscalco G, et al. Leukocyte filtration ameliorates the inflammatory response in patients with mild to moderate lung dysfunction. Ann Thoracic Surg 2011; 92: 111-121; discussion 121.
25. Sopena N. [Diagnostic methods and therapeutic approach in nonventilated nosocomial pneumonia patients]. Enferm Infecc Microbiol Clin 2005; 23: 517-518.
26. Sopena N, Sabria M, Neunos Study G. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127: 213-219.
27. Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative lowtidal-volume ventilation in abdominal surgery. N Engl J Med 2013; 369: 428-437.
28. Perkins GD, Gates S, Park D, et al. The beta agonist lung injury trial prevention. A randomized controlled trial. Am J Respir Crit Care Med 2014; 189: 674-683.
29. Hall WB, Willis LE, Medvedev S, Carson SS. The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay. Am J Respir Crit Care Med 2012; 185: 53-57.
30. Seguin P, Laviolle B, Dahyot-Fizelier C, et al. Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: a multicenter, randomized controlled trial. Crit Care Med 2014; 42: 1-8.
31. The Stages of Prevention. http: //phprimer.afmc.ca/Part1-TheoryThinking AboutHealth/Chapter4BasicConceptsInPreventionSurveillanceAndHealth Promotion/Thestagesofprevention.
32. Pandve HT. Quaternary prevention: need of the hour. J Family Med Prim Care 2014; 3: 309-310.
33. Halpern SD, Becker D, Curtis JR, et al. An official American Thoracic Society/ American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely top 5 list in critical care medicine. Am J Respir Crit Care Med 2014; 190: 818-826.
34. Kim JC, Hong SW, Shim JK, et al. Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. Acta Anaesthesiol Scand 2011; 55: 452-459.
35. Kim JC, Shim JK, Lee S, et al. Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest 2012; 142: 467-475.
36. Li C, Xu M, Wu Y, et al. Limb remote ischemic preconditioning attenuates lung injury after pulmonary resection under propofol-remifentanil anesthesia: a randomized controlled study. Anesthesiology 2014; 121: 249-259.
37. Kor DJ, Warner DO, Alsara A, et al. Derivation and diagnostic accuracy of the surgical lung injury prediction model. Anesthesiology 2011; 115: 117-128.
38. Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33: 1191-1198.
39. Gajic O, Dabbagh O, Park PK, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011; 183: 462-470.
40. Agrawal A, Matthay MA, Kangelaris KN, et al. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013; 187: 736-742.
41. Kor DJ, Talmor DS, Banner-Goodspeed VM, et al. Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open 2012; 2: e001606.
42. Levitt JE, Calfee CS, Goldstein BA, et al. Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation∗. Crit Care Med 2013; 41: 1929-1937.
43. Kor DJ, Lingineni RK, Gajic O, et al. Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study. Anesthesiology 2014; 120: 1168-1181.
44. Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014; 2: 611-620.
45. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567.
46. Watkins TR, Rubenfeld GD, Martin TR, et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med 2008; 36: 1493-1499.
47. Herring AA, Ginde AA, Fahimi J, et al. Increasing critical care admissions from U.S. emergency departments. Crit Care Med 2013; 41: 1197-1204.
48. Rohde JM, Odden AJ, Bonham C, et al. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013; 8: 243-247.
49. Chow SC. Adaptive clinical trial design. Ann Rev Med 2014; 65: 405-415.
50. Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci 2011; 13: 217-224.
51. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 2009; 10: 37.
52. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ 2009; 180: E47-E57.
53. Noto MJ, Domenico HJ, Byrne DW, et al. Chlorhexidine bathing and healthcare-associated infections: a randomized clinical trial. JAMA 2015; 313: 369-378.
54. Christie J, O'Halloran P, Stevenson M. Planning a cluster randomized controlled trial: methodological issues. Nurs Res 2009; 58: 128-134.
55. Li G, Malinchoc M, Cartin-Ceba R, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011; 183: 59-66.
56. Schoenfeld DA, Bernard GR, Network A. Statistical evaluation of ventilatorfree days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30: 1772-1777.
57. Heyland DK, Muscedere J, Drover J, et al. Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials. Crit Care 2011; 15: R98.
58. Hopkins RO, Weaver LK, Collingridge D, et al. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171: 340-347.
59. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693.
60. Herridge MS, Tansey CM, Matte A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364: 1293-1304.